267 related articles for article (PubMed ID: 32035102)
1. Cell cycle regulators in cancer cell metabolism.
Leal-Esteban LC; Fajas L
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165715. PubMed ID: 32035102
[TBL] [Abstract][Full Text] [Related]
2. The multifaceted role of cell cycle regulators in the coordination of growth and metabolism.
Huber K; Mestres-Arenas A; Fajas L; Leal-Esteban LC
FEBS J; 2021 Jun; 288(12):3813-3833. PubMed ID: 33030287
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
Klein MA
Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
[TBL] [Abstract][Full Text] [Related]
4. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
Łukasik P; Załuski M; Gutowska I
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805800
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
Santo L; Siu KT; Raje N
Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
[TBL] [Abstract][Full Text] [Related]
7. Molecular systems biology of Sic1 in yeast cell cycle regulation through multiscale modeling.
Barberis M
Adv Exp Med Biol; 2012; 736():135-67. PubMed ID: 22161326
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
9. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
10. Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Expert Opin Investig Drugs; 2006 Jan; 15(1):23-38. PubMed ID: 16370931
[TBL] [Abstract][Full Text] [Related]
11. Role of cell cycle regulators in adipose tissue and whole body energy homeostasis.
Lopez-Mejia IC; Castillo-Armengol J; Lagarrigue S; Fajas L
Cell Mol Life Sci; 2018 Mar; 75(6):975-987. PubMed ID: 28988292
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation by long non-coding RNAs.
Kitagawa M; Kitagawa K; Kotake Y; Niida H; Ohhata T
Cell Mol Life Sci; 2013 Dec; 70(24):4785-94. PubMed ID: 23880895
[TBL] [Abstract][Full Text] [Related]
13. Novel plant-specific cyclin-dependent kinase inhibitors induced by biotic and abiotic stresses.
Peres A; Churchman ML; Hariharan S; Himanen K; Verkest A; Vandepoele K; Magyar Z; Hatzfeld Y; Van Der Schueren E; Beemster GT; Frankard V; Larkin JC; Inzé D; De Veylder L
J Biol Chem; 2007 Aug; 282(35):25588-96. PubMed ID: 17599908
[TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
15. Metabolic adaptation to cancer growth: from the cell to the organism.
Escoté X; Fajas L
Cancer Lett; 2015 Jan; 356(2 Pt A):171-5. PubMed ID: 24709629
[TBL] [Abstract][Full Text] [Related]
16. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
Lee YM; Sicinski P
Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
[TBL] [Abstract][Full Text] [Related]
17. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
Sugatani J; Osabe M; Kurosawa M; Kitamura N; Ikari A; Miwa M
Drug Metab Dispos; 2010 Jan; 38(1):177-86. PubMed ID: 19797611
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle control and plant development.
Inagaki S; Umeda M
Int Rev Cell Mol Biol; 2011; 291():227-61. PubMed ID: 22017978
[TBL] [Abstract][Full Text] [Related]
19. New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy.
Bury M; Le Calvé B; Ferbeyre G; Blank V; Lessard F
Trends Cell Biol; 2021 May; 31(5):331-344. PubMed ID: 33676803
[TBL] [Abstract][Full Text] [Related]
20. Whether to target single or multiple CDKs for therapy? That is the question.
Węsierska-Gądek J; Maurer M; Zulehner N; Komina O
J Cell Physiol; 2011 Feb; 226(2):341-9. PubMed ID: 20836132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
